![]() Volkmann und Kollegen GbR, Code R (Recipient), Attack Adjudication Committee for Alexion and Horizon Therapeutics (formerly MedImmune/Viela Bio), Code S (non-remunerative) Anthony Traboulsee Genzyme, Roche, and Novartis, Code C (Consultant/Contractor), Genzyme and Roche, Code R (Recipient) Michael Yeaman Roche and Alexion, Code C (Consultant/Contractor), NIH and DoD, Code F (Financial Support), NovaDigm Therapeutics, Inc. ![]() Commercial Relationships Shervin Gholizadeh Moghaddam Genentech Inc., Code E (Employment) Jeffrey Bennett Mallinckrodt, Novartis, and the National Institutes of Health, Code F (Financial Support), Aquaporumab, Code P (Patent), Chugai Pharmaceutical,Viela Bio, Mitsubishi-Tanabe, Reistone Bio, Abbvie, Clene Neuroscience, Alexion, Genentech, and Roche, Code R (Recipient) Edward Fox AbbVie, Biogen, Celgene, Chugai, EMD Serono, Genentech/Roche, MedDay, Novartis, Sanofi Genzyme, and TG, Code C (Consultant/Contractor), AbbVie, Biogen, Celgene, Chugai, EMD Serono, Genentech/Roche, MedDay, Novartis, Sanofi Genzyme, and TG, Code R (Recipient) Benjamin Greenberg Alexion, Novartis, EMD Serono, Viela Bio, Genentech/Roche, Greenwich Biosciences, Axon Advisors, Rubin Anders, ABCAM, Signant, IQVIA, Sandoz, Druggability Technologies, Genzyme, and Immunovant, Code C (Consultant/Contractor), Clene Nanomedicine, Code F (Financial Support), UpToDate, Code R (Recipient) Brian Weinshenker UCB Biosciences, Mitsubishi Tanabe, Genentech, and Roche, Code C (Consultant/Contractor), NMO-IgG for diagnosis of neuromyelitis optica, Code P (Patent), Genentech, Roche, and Novartis, Code R (Recipient), Chugai, Code R (Recipient), RSR Ltd., Oxford University, Hospices Civils de Lyon, and MVZ Labor PD Dr. ![]()
0 Comments
Leave a Reply. |